Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia

International Psychogeriatrics

Volumn 13, Issue 4, 2001, Pages 465-475

  Howe, Michael N ^a   Price, Ian R ^a  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

Author keywords

At risk; Dementia; Memory; Nicotine; Preclinical

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; DEMENTIA; DOSE RESPONSE; FEMALE; HIGH RISK PATIENT; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; NAUSEA; PATHOGENESIS; PSYCHOMOTOR ACTIVITY; RECALL; SLEEP DISORDER; TASK PERFORMANCE; VERBAL BEHAVIOR; VOMITING;

ADULT; AGED; ALZHEIMER DISEASE; ATTENTION; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS; HUMANS; LEARNING; LONG-TERM CARE; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NICOTINE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RISK; VERBAL BEHAVIOR;

EID: 0035735272     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610201007888     Document Type: Article

References (42)

1. Apoe 4 and age at onset of Alzheimer's disease
2. Selective reminding for analysis of memory and learning
3. Evaluating storage, retention and retrieval in disordered memory and learning
4. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease
5. Nicotinic and muscarinic cholinergic receptor binding in human hippocampal formation during development and aging
6. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use
7. Human neuronal nicotinic receptors
8. Learning and retention in preclinical and early Alzheimer's disease
9. Efficacy of transdermal nicotine in dementia - A study using event related potentials and a middle latency response
10. Toward the prediction of dementia arising in the senium
11. Nicotinic systems and cognitive function
12. Persistence of chronic nicotine-induced cognitive facilitation
13. Development of nicotine drug therapy for cognitive disorders
14. The structure of neuronal nicotinic receptors
15. The preclinical phase of probable Alzheimer's disease
16. Distinguishing normal and dementing elderly with the Selective Reminding Test
17. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons
18. Nicotine, brain nicotinic receptors and neuropsychiatric disorders
19. The epidemiology of Alzheimer's disease - Beyond risk factors
20. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics
21. Human nicotinic receptors: Their role in aging and dementia
22. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography
23. Smoking and risk of dementia and Alzheimer's disease in a population based cohort: The Rotterdam study
24. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy Body diseases
25. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology
26. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals
27. Aging, memory and mild cognitive impairment
28. Apolipoprotein E4 allele as a predictor of cholinergic defects and treatment outcome in Alzheimer's disease
29. Nicotinic receptors in Alzheimer's disease
30. The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease
31. The apolipoprotein E gene and the risk of early onset Alzheimer's disease
32. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease
33. Risk factors for Alzheimer's disease: Overview of the EURODEM collaborative re-analysis of case-control studies
34. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease
35. Genesis of Alzheimer's disease
36. Transdermal nicotine administration in Alzheimer's disease: Effects on cognition, behaviour and cardiac function
37. Presynaptic nicotinic AcH receptors
38. Neuronal nicotinic acetycholine receptors in development and aging